English | Deutsch

m law group advised BioGents in series A financing


m law group advises BioGents in its conversion into a stock corporation and subsequent series A financing. The series A financing included private investors from Germany.

The equity shall be used for the expansion of BioGents’ business. BioGents, located in Regensburg, develops, produces and distributes attractants, repellents and traps for mosquitos.

BioGents is a winner of the “Development Marketplace 2007 Global Competition”, a USD 4 Mio. awarded competition of World Bank.

Counsel to BioGents:
m law group: Rainer Kreifels, Dr. Johannes Maidl.

Practice Area: Start-up & Venture Capital
Industry: Life Science & Biotech